文献速递先天性心脏病外科

房室间隔缺损患者Fontan循环中右心室优势而非瓣膜手术对生存率产生不良影响

Atrioventricular septal defect in Fontan circulation: Right ventricular dominance, not valve surgery, adversely affects survival.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-04-20

基于澳大利亚和新西兰Fontan登记处1987至2021年1703例患者的回顾性研究,其中174例为房室间隔缺损(AVSD)。右心室优势者25年无移植生存率67%,显著低于左心室优势者的94%(HR 5.9,95%CI 1.4-25.4,P<.01);而两组中度以上共同房室瓣反流累积发生率无显著差异,Fontan完成前或同期行房室瓣手术与未手术者无移植生存率亦无显著差异。

要点

  • AVSD合并Fontan循环患者中,右心室优势者25年无移植生存率67%,左心室优势者94%,右心室优势是死亡或移植的危险因素。
  • 左心室优势与右心室优势患者25年中度以上共同房室瓣反流累积发生率分别为56%和54%,无显著差异(P=.6)。
  • Fontan完成前或同期行房室瓣手术与未行手术者15年无移植生存率分别为81%和88%,无显著差异(P=.3)。

核心结论

  • 在AVSD合并Fontan循环患者中,左心室优势与右心室优势者的中度以上共同房室瓣反流发生率相似;右心室优势而非既往房室瓣手术是死亡或移植的危险因素。

研究设计与样本

  • 回顾性研究,纳入澳大利亚和新西兰Fontan登记处1987年至2021年间存活出院的1703例Fontan手术患者,其中174例为房室间隔缺损(AVSD)。

主要发现

  • 174例AVSD患者中,60%(105/174)为右心室优势,40%(69/174)为左心室优势。
  • 左心室优势者Fontan术后25年中度以上房室瓣反流累积发生率为56%(95%CI 35%-72%),右心室优势者为54%(95%CI 40%-67%),P=.6。
  • 左心室优势者25年无移植生存率为94%(95%CI 86%-100%),右心室优势者为67%(95%CI 52%-87%),风险比(HR)5.9(95%CI 1.4-25.4),P<.01。
  • Fontan完成前或同期行房室瓣手术者与未行手术者15年无移植生存率分别为81%(95%CI 62%-100%)和88%(95%CI 81%-95%),P=.3。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The effect of ventricular dominance and previous atrioventricular valve (AVV) surgery on patient outcomes after Fontan operation remains unclear. We sought to determine the effect of ventricular dominance and previous AVV surgery on transplantation-free survival and long-term AVV competency in patients with atrioventricular septal defect (AVSD) and Fontan circulation. METHODS: We conducted a retrospective study of 1703 patients in the Australia and New Zealand Fontan Registry, who survived Fontan operation between 1987 and 2021. RESULTS: Of 174 patients with AVSD, 60% (105/174) had right ventricular (RV) dominance and 40% (69/174) had left ventricular (LV) dominance. The cumulative incidence of moderate or greater AVV regurgitation at 25 years after Fontan operation in patients with LV dominance was 56% (95% CI, 35%-72%), compared with 54% (95% CI, 40%-67%) in patients with RV dominance (P = .6). Nonetheless, transplantation-free survival at 25 years in patients with LV dominance was 94% (95% CI, 86%-100%), compared with 67% (95% CI, 52%-87%) in patients with RV dominance (hazard ratio, 5.9; 95% CI, 1.4-25.4; P < .01). Of note, transplantation-free survival was not different in patients who underwent AVV surgery before or at Fontan completion compared with those who did not (15 years: 81% [95% CI, 62%-100%] vs 88% [95% CI, 81%-95%]; P = .3). CONCLUSIONS: In patients with AVSD and Fontan circulation the rate of moderate or greater common AVV regurgitation is similar in those with LV and RV dominance. RV dominance, rather than previous AVV surgery, is a risk factor for death or transplantation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. King G, Buratto E, Cordina R, et al. Atrioventricular septal defect in Fontan circulation: Right ventricular dominance, not valve surgery, adversely affects survival. J Thorac Cardiovasc Surg. 2022. PMID: 36008181. doi:10.1016/j.jtcvs.2022.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。